|View printer-friendly version|
|Portola Announces Pricing of Public Offering of Common Stock|
SOUTH SAN FRANCISCO, Calif.,
A registration statement relating to these securities has been filed with, and was declared effective by, the
Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the completion of the offering. Risks that contribute to the uncertain nature of the forward-looking statements include uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all. These and other risks and uncertainties are described more fully in Portola's filings with the
*PRT4445 has a proposed International Nonproprietary Name (pINN) of Andexanet alfa.